A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee

Trial Profile

A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs Autologous chondrocyte implantation (Primary)
  • Indications Cartilage disorders; Knee injuries
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Histogenics Corporation
  • Most Recent Events

    • 11 Jan 2017 MRI data through 60 months follow up from this and a phase I trial of NeoCart published online in the American Journal of Sports Medicine.
    • 10 Mar 2016 According to a Histogenics Corporation media release, the company expects to publish five-year data and MRI data from this trial in 2016.
    • 22 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top